Department of Intensive Care Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Department of Anesthesia and Pain Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Eur Heart J Acute Cardiovasc Care. 2023 Aug 24;12(8):540-547. doi: 10.1093/ehjacc/zuad071.
Extracorporeal cardiopulmonary resuscitation is a promising treatment for refractory out-of-hospital cardiac arrest. Three recent randomized trials (ARREST trial, Prague OHCA study, and INCEPTION trial) that addressed the clinical benefit of extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest yielded seemingly diverging results. The evidence for extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest, derived from three recent randomized controlled trials, is not contradictory but rather complementary. Excellent results can be achieved with a very high level of dedication, provided that strict selection criteria are applied. However, pragmatic implementation of extracorporeal cardiopulmonary resuscitation does not necessarily lead to improved outcome of refractory out-of-hospital cardiac arrest. Centres that are performing extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest or aspire to do so should critically evaluate whether they are able to meet the pre-requisites that are needed to conduct an effective extracorporeal cardiopulmonary resuscitation programme.
体外心肺复苏术是一种有前途的难治性院外心脏骤停治疗方法。三项最近的随机试验(ARREST 试验、布拉格 OHCA 研究和 INCEPTION 试验)解决了体外心肺复苏术在院外心脏骤停中的临床益处,得出了看似不同的结果。来自三项最近的随机对照试验的体外心肺复苏术在院外心脏骤停中的证据并非相互矛盾,而是相辅相成的。如果严格应用选择标准,可以获得非常高的卓越结果。然而,体外心肺复苏术的实际实施并不一定会导致难治性院外心脏骤停的结局改善。正在进行或渴望进行院外心脏骤停体外心肺复苏术的中心应严格评估他们是否有能力满足开展有效的体外心肺复苏术项目所需的前提条件。